Kiniciti
Overview
Kiniciti is a buy-and-build investment platform that partners with and invests in non-therapeutic service, tools, and technology companies to support and enable innovation in the cell and gene therapy (CGT) industry. The firm's investment focus includes companies with capabilities in cell engineering, gene-editing, cell sources, process development and scale-up tools, and production technologies. It was formed as a strategic partnership with private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and is also backed by Biospring Partners.
Portfolio Companies
2
Website
kiniciti.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cellistic | Nov 2021 | Corporate Funding | Lead |
For institutional investors. Book with your work email.
Key People
Geoffrey Glass
Member Board Of Directors, Chief Executive Officer
Michelle Detwiler
Board of Directors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kiniciti based?
Kiniciti is headquartered in New York City, New York, United States.
When was Kiniciti founded?
Founding year information for Kiniciti is not publicly available.
How many portfolio companies does Kiniciti have?
Kiniciti has 2 portfolio companies in Caplight's dataset.
What are some companies in Kiniciti's portfolio?
Portfolio companies visible on Caplight include Cellistic.
What was Kiniciti's most recent investment shown here?
Kiniciti's most recent investment in this portfolio sample was in Cellistic in 2021.
What sectors does Kiniciti focus on?
Kiniciti focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Kiniciti focus on?
Stage focus information for Kiniciti is not publicly available.